Muscular Dystrophy, Duchenne
-
Subject Areas on Research
-
A Transition Toolkit for Duchenne Muscular Dystrophy.
-
A step toward the future of seamless measurement with wearable sensors in pediatric populations with neuromuscular diseases.
-
AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic mice.
-
AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult Mice.
-
Acute heart failure during spinal surgery in a boy with Duchenne muscular dystrophy.
-
Airway clearance in Duchenne muscular dystrophy.
-
An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan.
-
An unusual cause of dyspnoea in a young man.
-
Ataluren treatment of patients with nonsense mutation dystrophinopathy.
-
Clinical and genetic characterization of manifesting carriers of DMD mutations.
-
Commentary on "Progression of Ankle Plantarflexion Contractures and Functional Decline in Duchenne Muscular Dystrophy: Implications for Physical Therapy Management".
-
Commentary on "Supported Standing in Boys With Duchenne Muscular Dystrophy".
-
Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis.
-
Comparison of right and left ventricular function and size in Duchenne muscular dystrophy.
-
Correction of dystrophin expression in cells from Duchenne muscular dystrophy patients through genomic excision of exon 51 by zinc finger nucleases.
-
Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols.
-
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.
-
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.
-
Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management.
-
Duchenne muscular dystrophy and steroids: pharmacologic treatment in the absence of effective gene therapy.
-
Dystrophin immunity in Duchenne's muscular dystrophy.
-
Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer.
-
Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance.
-
Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study.
-
Evaluation of skeletal and cardiac muscle function after chronic administration of thymosin beta-4 in the dystrophin deficient mouse.
-
Exercise and Duchenne muscular dystrophy: where we have been and where we need to go.
-
Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular Dystrophy.
-
Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy.
-
Gene therapy as a potential therapeutic option for Duchenne muscular dystrophy: A qualitative preference study of patients and parents.
-
Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-up.
-
In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.
-
Inefficient dystrophin expression after cord blood transplantation in Duchenne muscular dystrophy.
-
Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade.
-
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy.
-
Losartan decreases cardiac muscle fibrosis and improves cardiac function in dystrophin-deficient mdx mice.
-
Membrane sealant Poloxamer P188 protects against isoproterenol induced cardiomyopathy in dystrophin deficient mice.
-
Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.
-
Motor axonopathies in a mouse model of Duchenne muscular dystrophy.
-
Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy.
-
Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy: A Randomized Clinical Trial.
-
Myocardial Fibrosis in Duchenne and Becker Muscular Dystrophy-Reply.
-
Non-invasive MRI and spectroscopy of mdx mice reveal temporal changes in dystrophic muscle imaging and in energy deficits.
-
Orthopedic and Surgical Management of the Patient With Duchenne Muscular Dystrophy.
-
Patterns of left ventricular remodeling in patients with Duchenne Muscular Dystrophy: a cardiac MRI study of ventricular geometry, global function, and strain.
-
Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector.
-
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug.
-
Physiology of nitric oxide in skeletal muscle.
-
Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures.
-
Presence of mechanical dyssynchrony in Duchenne muscular dystrophy.
-
Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function.
-
Priorities when deciding on participation in early-phase gene therapy trials for Duchenne muscular dystrophy: a best-worst scaling experiment in caregivers and adult patients.
-
Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients.
-
Regional circumferential strain is a biomarker for disease severity in duchenne muscular dystrophy heart disease: a cross-sectional study.
-
Rehabilitation Management of the Patient With Duchenne Muscular Dystrophy.
-
Relationship of Right Ventricular Size and Function with Respiratory Status in Duchenne Muscular Dystrophy.
-
Respiratory Management of the Patient With Duchenne Muscular Dystrophy.
-
Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement.
-
Should foot surgery be performed for children with Duchenne muscular dystrophy?
-
Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophy.
-
Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy.
-
Suppression of revertant fibers in mdx mice by expression of a functional dystrophin.
-
The CINRG Becker Natural History Study: Baseline characteristics.
-
The Canadian experience with long-term deflazacort treatment in Duchenne muscular dystrophy.
-
The care of patients with Duchenne, Becker, and other muscular dystrophies in the COVID-19 pandemic.
-
The respiratory management of patients with duchenne muscular dystrophy: a DMD care considerations working group specialty article.
-
The role of corticosteroids in Duchenne muscular dystrophy: a review for the anesthetist.
-
Ultra-widefield imaging of Duchenne muscular dystrophy-associated proliferative retinal vasculopathy improved with panretinal laser photocoagulation alone.
-
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function.
-
Keywords of People